Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aethlon Medical (AEMD) Enterprise Value (2016 - 2025)

Aethlon Medical filings provide 15 years of Enterprise Value readings, the most recent being -$5.5 million for Q1 2025.

  • On a quarterly basis, Enterprise Value rose 0.51% to -$5.5 million in Q1 2025 year-over-year; TTM through Mar 2025 was -$5.5 million, a 0.51% increase, with the full-year FY2025 number at -$5.5 million, up 0.51% from a year prior.
  • Enterprise Value hit -$5.5 million in Q1 2025 for Aethlon Medical, down from -$4.9 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$4.9 million in Q4 2024 to a low of -$25.4 million in Q2 2021.
  • Median Enterprise Value over the past 5 years was -$13.0 million (2023), compared with a mean of -$13.3 million.
  • Biggest five-year swings in Enterprise Value: tumbled 72.24% in 2022 and later surged 62.18% in 2024.
  • Aethlon Medical's Enterprise Value stood at -$20.6 million in 2021, then increased by 15.15% to -$17.5 million in 2022, then surged by 54.44% to -$8.0 million in 2023, then surged by 38.37% to -$4.9 million in 2024, then fell by 11.98% to -$5.5 million in 2025.
  • The last three reported values for Enterprise Value were -$5.5 million (Q1 2025), -$4.9 million (Q4 2024), and -$6.9 million (Q3 2024) per Business Quant data.